31947-44-1Relevant articles and documents
FERROPTOSIS INHIBITORS–DIARYLAMINE PARA-ACETAMIDES
-
Paragraph 01142-01143; 01158-01159, (2021/09/11)
Provided are compounds that inhibit ferroptosis activity, or modulate or inhibit a disease associated with ferroptosis dysregulation, such as neuropathy, ischemia reperfusion injury, acute kidney failure and cancer, including corresponding sulfonamides, and pharmaceutically acceptable salts, hydrates and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant improvement in the person's health or condition.
Structural studies of some 1-polymethyleneimino-2,4-dinitrobenzenes and related compounds; Crystal structure of 1-(cis-2′,6′-dimethylpiperidin-l′-yl)-2,4-dinitrobenzene
Mackay, Maureen F.,Gale, Douglas J.,Wilshire, John F. K.
, p. 715 - 722 (2007/10/03)
The ultraviolet and 1H n.m.r. spectra of some 1-polymethyleneimino-2,4-dinitrobenzenes and related compounds are discussed. The effect of trifluoroacetic acid on these spectra was also investigated; with 1-azetidiny 1-2,4-dinitrobenzene, acid-c